Buy Pantina Cosmetics
DOWNLOAD ->>> https://shurll.com/2tEtgO
The trend is driven by two major preoccupations in the cosmetics market: antiaging and naturals. Makeup brands with antiaging benefits have induced a $39 million growth in the category in the past two years, according to market information provider Mintel.
Perstorp claims its materials palette can achieve durability and substantivity in cosmetics while securing essential properties, such as adhesion and gloss, and emphasizing skin feel and waterproofing in lipsticks and mascara.
Within color cosmetics, lip plumpers and multipurpose lip/eye/cheek products are said to be the main market drivers of the future. Natural Swedish direct sales firm Oriflame recently launched two lip plumper and booster product ranges, capitalizing on the growing consumer trend for fuller pouts. The products, Beauty Gloss Booster and Beauty Gloss Power Shine, arrived on the market at a time when studies show that lip glosses and alternative products are driving the lip product category despite declined lipstick sales.
New research finds the major drivers of market growth are the mainstreaming of natural and organic cosmetics, inward investment and growing consumer demand for green products. Investment is coming primarily from retailers, especially in Europe, and large cosmetic manufacturers that are either acquiring dedicated natural and organic cosmetic companies or launching certified products.
The broad market that Telomolecular competes in is considered the "global cosmetics market", the global "pharmaceuticals market" and possibly the global "natural food supplements" market. Specific market applications take the form of treatments for agerelated diseases that are caused by critical telomere shortening and a wider market for the treatment of aging in generic ways. Synergistic and complimentary products are likely to be added to our patent and licensing portfolio.
According to Dr. Harley in an article written by Discover Magazine in June of 1999, "You could try to deliver a telomerase activator in a cream," he suggests. "It would penetrate the skin, get into the cells, and keep them from aging." Generally, even in liposome-based cosmetics, the FDA does not interfere with the sale of products if it can be demonstrated that they meet those safety guidelines required in the industry. Many foreign markets are even more lenient. It is likely that there will be real markets for cosmeceutical products. Management anticipates a rejuvenating skin cream to be developed, tested and ready for initial marketing within 48 months of the start of development.
The production of a liposome or nanoparticle formulation that can be applied directly on the skin makes an in vivo product viable.Cosmetics production enjoys inherent marketplace advantages.In regulated markets approvals for "cosmetic claims only" are minimal and take months, not years. Cosmetics are easier to develop and administer than pharmaceuticals.Development costs for a first commercial product are lower (overall costs of US $3 million over a one year period).The technology is safe and readily available for effective delivery to the basal layer of the skin (liposome or nanoparticle technology).The world market for such an effective cosmetic product is in the many billions.Existing cosmetic surgery clinics, health and beauty spas and clinics, anti- aging clinics provide a rapid market entry vehicle through the franchising and licensing of "clinics" to be operated within existing clinics and spas who service and can be expected to expand their present clientele. Results of the cosmetics testing form the basis for further testing and an application for a DIN (drug identification number) for the product with medical claims. This process is generally faster for topical (skin) applications than for more invasive types of delivery. "The term cosmeceutical refers to a skin treatment that provides added benefits beyond a simple cosmetic. Cosmeceuticals are not considered a medication and therefore not regulated by the FDA. " - Nicholas Perricone, M.D. 781b155fdc